AtriCure (ATRC) Change in Receivables (2010 - 2026)

AtriCure (ATRC) has reported Change in Receivables for 17 consecutive years, with $8.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Receivables rose 305.98% year-over-year to $8.8 million; the TTM figure through Jun 2026 stood at $14.5 million (up 45.26% YoY), while the FY2025 annual figure was $5.6 million, down 32.42% from the prior year.
• Change in Receivables advanced to $8.8 million in Q2 2026 per ATRC's latest filing, from $5.0 million in the prior quarter.
• Across five years, Change in Receivables topped out at $8.8 million in Q2 2026 and bottomed at -$3.0 million in Q3 2025.
• Historically, Change in Receivables has averaged $2.6 million across 5 years, with a median of $2.7 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Receivables jumped 23200.0% — and 2025, when it plunged 234.71%.
• AtriCure's Change in Receivables stood at $4000.0 in 2022, then surged by 23200.0% to $932000.0 in 2023, then soared by 550.54% to $6.1 million in 2024, then slumped by 38.07% to $3.8 million in 2025, then surged by 133.32% to $8.8 million in 2026.
• Business Quant data shows ATRC's Change in Receivables at $8.8 million in Q2 2026, $5.0 million in Q1 2026, and $3.8 million in Q4 2025.